Latest News and Press Releases
Want to stay updated on the latest news?
-
PHILADELPHIA, Nov. 11, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Selecta Biosciences, Inc. (NASDAQ: SELB) (“Selecta”) on behalf of the company’s investors. Since...
-
PHILADELPHIA, Nov. 11, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Rekor Systems, Inc. (NASDAQ: REKR) (“Rekor”) on behalf of the company’s investors. Since August...
-
PHILADELPHIA, Nov. 11, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase”) on behalf of the company’s investors. Since May...
-
PHILADELPHIA, Nov. 11, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Precision BioSciences, Inc. (NASDAQ: DTIL) (“Precision”) on behalf of the company’s investors. ...
-
PHILADELPHIA, Nov. 11, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) (“Phathom”) on behalf of the company’s investors. ...
-
PHILADELPHIA, Nov. 11, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Ooma, Inc. (NYSE: OOMA) (“Ooma”) on behalf of the company’s investors. Since June 2023, shares...
-
PHILADELPHIA, Nov. 11, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Nkarta, Inc. (NASDAQ: NKTX) (“Nkarta”) on behalf of the company’s investors. Since June 2023,...
-
PHILADELPHIA, Nov. 11, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Medifast, Inc. (NYSE: MED) (“Medifast”) on behalf of the company’s investors. Since July 2023,...
-
PHILADELPHIA, Nov. 11, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Lyra Therapeutics, Inc. (NASDAQ: LYRA) (“Lyra”) on behalf of the company’s investors. Since August...
-
PHILADELPHIA, Nov. 11, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating JELD-WEN Holding, Inc. (NYSE: JELD) (“JELD-WEN”) on behalf of the company’s investors. Since...